SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001829126-22-014492
Filing Date
2022-07-19
Accepted
2022-07-19 16:41:39
Documents
14
Period of Report
2022-07-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K organicell_8k.htm   iXBRL 8-K 45861
2 EXHIBIT 10.1 organicell_ex10-1.htm EX-10.1 69760
3 EXHIBIT 10.2 organicell_ex10-2.htm EX-10.2 50320
  Complete submission text file 0001829126-22-014492.txt   352841

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bpsr-20220713.xsd EX-101.SCH 2965
5 XBRL LABEL FILE bpsr-20220713_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE bpsr-20220713_pre.xml EX-101.PRE 22363
8 EXTRACTED XBRL INSTANCE DOCUMENT organicell_8k_htm.xml XML 3303
Mailing Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140
Business Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-55008 | Film No.: 221091965
SIC: 3790 Miscellaneous Transportation Equipment